Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today
Update: 2025-10-31
Description
Tandem Diabetes shares dropped four percent on October 31st, following DexCom's less optimistic growth forecast, despite beating earnings and revenue estimates. Despite this, Tandem's shares have been volatile, with forty moves larger than five percent in the past year. However, the stock is down over sixty percent since January, trading below its fifty-two week high. Despite this, the diabetes tech market has a bullish long-term outlook, with the US insulin pump market projected to grow to over two and a half billion dollars by 2033.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
